Evidence map›Paper›PMID 39387039›Full record

ArticleRadiology case reports2024

Transdiaphragmatic extension of a thymoma invading the peritoneum and the spleen.

Kenza Horache, Manal Jidal, Ola Messaoud, Youssef Omor, Rachida Latib, Sanae Amalik

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kenza HoracheRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.
Manal JidalRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.
Ola MessaoudRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.
Youssef OmorRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.
Rachida LatibRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.
Sanae AmalikRadiology Department, National Institute of Oncology, University of Medicine and pharmacy of Rabat, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymoma, a rare tumor originating from thymic epithelial cells in the anterior mediastinum, presents various diagnostic and clinical challenges, particularly when exhibiting unusual invasive behaviors. We report a case involving a 66-year-old woman with progressive dyspnea and a dry cough, where a CT scan revealed a large, lobulated mass in the anterior mediastinum that had extended through the diaphragm into the abdominal cavity, infiltrating the pleura, spleen, and adjacent structures. Histopathological examination confirmed a type B2 thymoma, classified as T3N2M0 stage IV B. The case underscores the importance of early and accurate diagnosis, highlighting the need for a multidisciplinary approach involving radiologists, oncologists, and thoracic surgeons to manage such advanced thymoma cases. The unusual transdiaphragmatic extension into the peritoneum and spleen emphasizes the necessity of considering extensive local invasion in the staging and treatment planning of thymomas, which often necessitates a combination of chemotherapy and radiotherapy before potential surgical intervention.

Indexed as

Anterior mediastinumCT scanMasaoka-Koga stagingPeritoneal invasionThymoma

Identifiers

PMID39387039
PMCPMC11461953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.